Presentation Information
[O-39-6]AIM/CD5L promotes phagocytic removal of amyloid-beta thereby improving Alzheimer's disease
Natsumi Maehara, Satoko Arai, Toru Miyazaki (Department of Molecular Biomedicine for Pathogenesis, The Institute for AIM Medicine, Japan)